Total Payments
$47,918
2019 Payments
$21,739
Companies
7
Transactions
47
Payment Breakdown by Category
Consulting$44,625 (93.1%)
Travel$2,378 (5.0%)
Food & Beverage$901.83 (1.9%)
Research$13.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $44,625 | 8 | 93.1% |
| Travel and Lodging | $2,378 | 13 | 5.0% |
| Food and Beverage | $901.83 | 25 | 1.9% |
| Unspecified | $13.89 | 1 | 0.0% |
Payments by Type
General
$47,905
46 transactions
Research
$13.89
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $42,836 | 38 | $0 (2019) |
| Ironwood Pharmaceuticals, Inc | $4,967 | 3 | $0 (2017) |
| UCB, Inc. | $34.80 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $34.50 | 2 | $0 (2018) |
| GENZYME CORPORATION | $23.42 | 1 | $0 (2018) |
| PFIZER INC. | $12.68 | 1 | $0 (2017) |
| West-Ward Pharmaceuticals | $10.57 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $21,739 | 32 | Takeda Pharmaceuticals U.S.A., Inc. ($21,704) |
| 2018 | $19,070 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($19,031) |
| 2017 | $7,110 | 7 | Ironwood Pharmaceuticals, Inc ($4,967) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/18/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $34.80 | General |
| Category: Immunology | ||||||
| 01/28/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Consulting Fee | Cash or cash equivalent | $13,125.00 | General |
| Category: Gout/Rheumatology | ||||||
| 01/28/2019 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | Cash or cash equivalent | $488.00 | General |
| 01/28/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | Cash or cash equivalent | $78.67 | General |
| Category: Gout/Rheumatology | ||||||
| 01/17/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| Category: Gout/Rheumatology | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $159.00 | General |
| Category: Gout/Rheumatology | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $90.00 | General |
| Category: Gout/Rheumatology | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $66.54 | General |
| Category: Gout/Rheumatology | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $52.40 | General |
| Category: Gout/Rheumatology | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $37.50 | General |
| Category: Gout/Rheumatology | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Gout/Rheumatology | ||||||
| 01/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Gout/Rheumatology | ||||||
| 01/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: Gout/Rheumatology | ||||||
| 01/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $42.80 | General |
| Category: Gout/Rheumatology | ||||||
| 01/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $42.80 | General |
| Category: Gout/Rheumatology | ||||||
| 01/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Gout/Rheumatology | ||||||
| 01/10/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Gout/Rheumatology | ||||||
| 01/09/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $200.71 | General |
| Category: Gout/Rheumatology | ||||||
| 01/09/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: Gout/Rheumatology | ||||||
| 01/09/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $49.56 | General |
| Category: Gout/Rheumatology | ||||||
| 01/09/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $42.80 | General |
| Category: Gout/Rheumatology | ||||||
| 01/09/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Gout/Rheumatology | ||||||
| 01/09/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: Gout/Rheumatology | ||||||
| 01/08/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $145.77 | General |
| Category: Gout/Rheumatology | ||||||
| 01/04/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Travel and Lodging | In-kind items and services | $133.05 | General |
| Category: Gout/Rheumatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Gout Subjects With Cardiovascular Comorbidities and Hyperuricemia | Takeda Pharmaceuticals U.S.A., Inc. | $13.89 | 1 |
About Dr. Michael Becker, MD
Dr. Michael Becker, MD is a Rheumatology healthcare provider based in Burr Ridge, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992867444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Becker, MD has received a total of $47,918 in payments from pharmaceutical and medical device companies, with $21,739 received in 2019. These payments were reported across 47 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($44,625).
Ad
Practice Information
- Specialty Rheumatology
- Location Burr Ridge, IL
- Active Since 12/14/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1992867444
Products in Payments
- Uloric (Drug) $42,348
- ZURAMPIC (Drug) $4,967
- Cimzia (Drug) $34.80
- ORENCIA (Biological) $34.50
- KEVZARA (Drug) $23.42
- CHANTIX (Drug) $12.68
- Mitigare (Drug) $10.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.